Nicole is a domain expert in the microbiome and data science with more than 20 years of experience, with the last 6 years in startups doing everything from marketing, business strategy, IP, data analysis, and fundraising. She studied at the University of Michigan and University of Chicago with Dr. Jack Gilbert, and was the first employee at Dr. Rob Knight’s microbiome startup Biota. She is cited more than 3000 times, published in prestigious journals such as Science and Nature, is the author of several book chapters and patents and is an active member of several NSF grant committees. She also serves as an advisor to several other startups in biotech.
Rita Colwell, Johns Hopkins Bloomberg School of Public Health
Manoj Dadlani, CosmosID
Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.